Age-associated clonal B cells drive B cell lymphoma in mice.

Castro, José P; Shindyapina, Anastasia V; Barbieri, Alessandro; Ying, Kejun; Strelkova, Olga S; Paulo, João A; Tyshkovskiy, Alexander; Meinl, Rico et al. · Nat Aging · 2024

basic_science · Level V

Where this comes from

Abstract

Although cancer is an age-related disease, how the processes of aging contribute to cancer progression is not well understood. In this study, we uncovered how mouse B cell lymphoma develops as a consequence of a naturally aged system. We show here that this malignancy is associated with an age-associated clonal B cell (ACBC) population that likely originates from age-associated B cells. Driven by c-Myc activation, promoter hypermethylation and somatic mutations, IgM<sup>+</sup> ACBCs clonally expand independently of germinal centers and show increased biological age. ACBCs become self-sufficient and support malignancy when transferred into young recipients. Inhibition of mTOR or c-Myc in old mice attenuates pre-malignant changes in B cells during aging. Although the etiology of mouse and human B cell lymphomas is considered distinct, epigenetic changes in transformed mouse B cells are enriched for changes observed in human B cell lymphomas. Together, our findings characterize the spontaneous progression of cancer during aging through both cell-intrinsic and microenvironmental changes and suggest interventions for its prevention.

Medical subject headings